Daclatasvir dihydrochloride
CAS: 1009119-65-6
Ref. TM-T1786
1g | 238,00 € | ||
5mg | 41,00 € | ||
10mg | 50,00 € | ||
25mg | 60,00 € | ||
50mg | 70,00 € | ||
100mg | 80,00 € | ||
500mg | 167,00 € | ||
1ml*10 (DMSO) | 52,00 € |
Información del producto
- BMS-790052 dihydrochloride
- Bms 790052-05
- Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2)
- Daclatasvir.2HCL
- Daklinza
- N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice.
Propiedades químicas
Consulta técnica sobre: TM-T1786 Daclatasvir dihydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.